Evidence map›Paper›PMID 42410264›Full record

ArticleEMBO reports2026

Gata3 dosage governs primitive endoderm versus trophectoderm specification in embryonic stem cells.

Yeejin Jang, Mijeong Kim, Joonhyuk Choi, Jonghwan Kim

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yeejin Jang *Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, USA.ORCID 0009-0008-3640-8258
Mijeong Kim *Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, USA.
Joonhyuk ChoiDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, USA.ORCID 0000-0001-7677-5978
Jonghwan KimDepartment of Molecular Biosciences, The University of Texas at Austin, Austin, TX, 78712, USA. jonghwankim@mail.utexas.edu.ORCID 0000-0002-9919-9843

Funding

Investigating regulators controlling differentiation potential of ES cellsR01GM112722 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI KIM, JONGHWAN · 2015 to 2023
$2.8M
Deciphering gene regulatory networks modulating human trophoblast stem cell self-renewal and differentiationR01HD101512 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI KIM, JONGHWAN · 2021 to 2025
$2.3M
HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD101512HHS | NIH | National Institute of General Medical Sciences (NIGMS) R01GM112722NICHD NIH HHS R01 HD101512NIGMS NIH HHS R01 GM112722
6 · The paper itself

Abstract

Transcription factor (TF) dosage represents an overlooked aspect of developmental regulation. While Gata3 has traditionally been viewed as a determinant of trophectoderm (TE), its potential role in primitive endoderm (PE) has remained unclear. Here, we demonstrate that Gata3 functions as a dosage-sensitive regulator directing mutually exclusive lineage programs in mouse embryonic stem (ES) cells. Low levels of Gata3 (Gata3-L) promote PE-like transcriptional states, while high levels (Gata3-H) drive TE identity by rapidly repressing pluripotency and inducing TE markers. Genome-wide binding analysis reveals a dose-dependent redistribution of Gata3 across enhancers, with chromatin engagement consistent with pioneer factor-like activity. Functional 3D blastoid assays combined with single-cell transcriptomics further establish that Gata3 dosage alone is sufficient to instruct the spatial segregation of PE- versus TE-like compartments. These findings redefine Gata3 not merely as a TE determinant but as a central dosage-sensitive switch in lineage specification. More broadly, our results position TF dosage as a fundamental regulatory parameter that integrates enhancer selection, chromatin engagement, and spatial patterning, providing new opportunities to refine stem cell-based models and engineer developmental outcomes.

Indexed as

EctodermEmbryonic Stem CellsEndodermGATA3 Transcription FactorGene DosageMouse Embryonic Stem CellsAnimalsCell DifferentiationCell LineageChromatinEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalMiceChromatinGata3 protein, mouseGATA3 Transcription Factor

Identifiers

PMID42410264
PMCPMC13503713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.